Tiffany Reiter is an Associate in the Boston office of Fish & Richardson. Prior to joining the firm, Dr. Reiter was a postdoctoral fellow in the Department of Genetics and Complex Diseases at the Harvard School of Public Health.
Reiter, T.A, Baker, E.L., Fasse, J.P. (April 2012) The America Invents Act and Its Importance to Patent Prosecution in the Biotech Sector. Industrial Biotechnology.
Reiter, T.A, Fasse, J.P. (June 2011) Isolated, purified, covalent bonds, or magic microscopes? What defines patentable nucleic acid molecules? Industrial Biotechnology.
Reiter, T.A., Pang, B., Dedon, P., and Demple, B. (2006) Heme oxygenase-1 overexpression blocks NOinducednecrosis by preventing lipid peroxidation in human pulmonary epithelial cells. J. Biol. Chem.
Reiter, T. A. and Demple, B. (2005) Carbon monoxide mediates protection against nitric oxide toxicity in HeLa cells. Free Rad. Biol. Med. 39: 1075-1088.
Reiter, T. A.† and Rusnak, F. (2003) Electrochemical studies of the mono-Fe, Fe-Zn, and Fe-Fe metalloisoforms of bacteriophage l protein phosphatase. Biochemistry 43: 782-790.
Reiter, T. A., Reiter, N. J., and Rusnak, F. (2002) Mn2+ is a native metal ion activator for bacteriophage l protein phosphatase. Biochemistry 41: 15404-15409.
Reiter, T. A. and Rusnak, F. (2002) Is calcineurin a peroxide-sensor in T-lymphocytes? J. Biol. Inorg. Chem. 7: 823-834.
Reiter, T. A. and Rusnak, F. (2001) Measurement of calcineurin redox regulation in vivo. Methods Enzymology 353: 70-81.
Rusnak, F. and Reiter, T. (2000) Sensing electrons: protein phosphatase redox regulation. Trends Biomed. Sci. 25: 527-529.
Reiter, T. A., Abraham, R. T., Choi, M., and Rusnak, F. (1999) Redox regulation of calcineurin in Tlymphocytes. J. Biol. Inorg. Chem. 4: 632-644.
† Denotes T. Reiter as Corresponding Author.